Thrombosis Research

Article	Citations
Linezolid impair proplatelet formation by reducing mitochondrial energy metabolism in MEG-01 cells	49
Major in-hospital bleeding in patients with pulmonary embolism treated with systemic thrombolysis	42
Distinct Immunologic Mediators Are Associated with Venous Thromboembolism in Multiply Injured Patients	39
Investigation of the impact of antithrombin deficiency on the inflammatory response: Results from a single centre cohort study	38
Unveiling the predictive capacity of inflammatory and platelet markers for central retinal artery occlusion	37
Corrigendum to “Repurposing of rilpivirine for preventing platelet β3 integrin-dependent thrombosis by targeting c-Src active autophosphorylation” [Thromb. Res. 229 (2023) 53–68]	36
Editorial Board	36
Predicting post-discharge venous thromboembolism and bleeding among medical patients: External validation of a novel risk score utilizing ubiquitous biomarkers	33
The role of interleukin-10 gene variants in inhibitor development in hemophilia: A meta-analysis	33
DOACs: A perfect fit for patients with bariatric surgery?	32
Cost of immune tolerance induction according to its outcome in people with hemophilia A and inhibitors: results from the Co$tIT study	32
A novel role of acellular hemoglobin in hemolytic thrombosis	31
Thrombosis after surgical splenectomy – why, in whom and can we prevent it?	30
Assessing the risk of venous thromboembolism in trans masculine persons on gender-affirming hormone therapy: A literature review	28
Rivaroxaban plus aspirin versus acenocoumarol to manage recurrent venous thromboembolic events despite systemic anticoagulation with rivaroxaban	28
Treatment strategies, bleeding, long-term recurrence and mortality in abdominal vein thrombosis: Findings from the TROLL registry	27
Clinical outcomes of cancer-associated isolated superficial vein thrombosis in daily practice	27
Acute and subacute effects of strenuous exercise on platelet aggregation, coagulation and fibrinolysis in patients with stable coronary artery disease	27
Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patients	27
Decreased patency of transjugular intrahepatic portosystemic shunts performed for splanchnic vein thrombosis in patients with myeloproliferative neoplasms	27
Regulation of fibrinogen synthesis	26
The maternal hemostatic shift: Understanding VTE risk in pregnancy and postpartum	25
Prevalence and clinical outcomes associated with proximal deep vein thrombosis at hospital admission detected by bedside ultrasound in patients hospitalized in a medical oncology ward: An exploratory	25
Impact of aetiology and liver stiffness on thrombin generation in compensated cirrhosis	25
LY96–CCNT1–IFI44L core molecular features characterize VTE-associated inflammatory prothrombotic risk in elderly cancer patients	25

Prosthetic valve dysfunction in patients with mechanical heart valves: Results from the Emergency Salam Centre cohort	24
Is all collagen the same for platelet testing? Editorial on “Platelet collagen receptors and their role in modulating platelet adhesion patterns and activation on alternatively processed collagen subs	24
Myocardial ischemia-reperfusion injury released cellular fibronectin containing domain A (CFN-EDA): A destructive positive loop amplifying arterial thrombosis formation and exacerbating myocardial rep	23
Main features of ischemic stroke in patients with acute immune-mediated thrombotic thrombocytopenic purpura	23
Driver gene KRAS aggravates cancer-associated stroke outcomes	23
Safety of fixed-dose heparin titration boluses in underweight patients	22
D-dimer as a predictive biomarker for cancer-associated thrombosis: A prospective cohort study	22
Intrinsic coagulant potential modulates anticoagulant efficacy of rivaroxaban	22
A comprehensive review of the autoimmune pathogenesis of acquired hemophilia A	22
Editorial Board	22
Predicting functional outcomes after acute ischemic stroke – Is thrombelastography useful outside perioperative bleeding management?	22
Canadian Perspective on Superficial Vein Thrombosis in Pregnancy and Postpartum: Interim Results from a Tertiary Care Centre	22
In vitro procoagulant effects of Gla-domainless factor Xa in factor XI-deficient and factor IX-deficient plasma	21
Letter to the editor regarding the article “Platelet activity, coagulation, and fibrinolysis in long-term users of anabolic-androgenic steroids compared to strength-trained athletes”	21
Control of warfarin treatment in patients with antiphospholipid syndrome and falsely high INR at point-of-care-testing	21
D-dimer and risk of venous thromboembolism recurrence: Comparison of two studies with similar designs but different laboratory and clinical results	21
Identification of phenotypes and predictors for dyspnea, echocardiographic probability of pulmonary hypertension, and confirmed CTEPH in patients with acute pulmonary embolism: Analysis of two large p	20
Sex disparities of clinical manifestations in acute pulmonary embolism and predictive value for in-hospital mortality: Insights from CURES	20
Large deletions and small insertions and deletions in the factor VIII gene predict unfavorable immune tolerance induction outcome in people with severe hemophilia A and high-responding inhibitors	20
Real-time risk stratification in acute pulmonary embolism: the utility of RV/LV diameter ratio	20
Isolated subsegmental pulmonary embolism identification based on international classification of diseases (ICD)-10 codes and imaging reports	20
A survey on clinical practice in monitoring and management of bleeding in children with haemophilia A on emicizumab prophylaxis in the PedNet centres	20
Statin use and mortality in patients with deep vein thrombosis. Data from the RIETE Registry	20
To aPTT or not to aPTT: Evaluating the optimal monitoring strategy for unfractionated heparin	20
Rivaroxaban for pediatric venous thromboembolism in routine clinical practice: Effectiveness and safety from a real-world cohort	20
Venous thromboembolism in hematopoietic stem cell transplantation: A narrative review	20
Intracoronary antithrombotic therapy during primary percutaneous coronary intervention in patients with STEMI: A systematic review and network meta-analysis	19
CT coronary calcium score is a prognostic marker in acute pulmonary embolism	19
Abstracts from the CanVECTOR 2024 Annual Conference October 25th, 2024	19
The role of platelets in heat-related illness and heat-induced coagulopathy	19
Short-term performance of bleeding risk scores in anticoagulated older patients with acute pulmonary embolism	19
Heatstroke-induced coagulopathy: A scoping review of therapeutic strategies and outcome reporting	19
Risk factors for thrombocytopenia in adult patients with sepsis: A systematic review and meta-analysis	19
Procoagulant phenotype induced by oxidized high-density lipoprotein associates with acute kidney injury and death	18
Effect of lupus anti-coagulant and antiphospholipid antibodies on clot waveform analysis parameters	18
Editorial Board	18
Barriers and facilitators for adherence to direct oral anticoagulants in patients with atrial fibrillation: A qualitative approach	18
Changes in haemostasis and inflammatory markers after mRNA BNT162b2 and vector Ad26.CoV2.S SARS-CoV-2 vaccination	18
Editorial Board	18
Regulation of coagulation activation in newly diagnosed AML by the heme enzyme myeloperoxidase	18
Association between the simplified Pulmonary Embolism Severity Index (sPESI) score and hospitalization in emergency department patients diagnosed with pulmonary embolism	17
A noncanonical splicing variant c.875-5 T > G in von Willebrand factor causes in-frame exon skipping and type 2A von Willebrand disease	17
SSA-sMLP: A venous thromboembolism risk prediction model using separable self-attention and spatial-shift multilayer perceptrons	17
Safety and effectiveness of statins in hospitalized patients with COVID-19: Systematic review and collaborative meta-analysis of randomized controlled trials	17
Monitoring the Hemostatic Balance: measuring thrombin generation in a patient with acquired hemophilia A on combined pro- and anticoagulant therapy	17
Stroke mortality in cancer survivors: A population-based study in Japan	17
Optimizing therapeutic enoxaparin in preterm neonates and infants	17
The long haul COVID-19 arterial thrombosis	17
Low-dose immune tolerance induction therapy in severe hemophilia a children in China: Starting earlier resulted in better inhibitor eradication outcomes	17
Suitability and readiness assessment of organizational resources for the implementation of gene therapy in hemophilia in Spain and Portugal: A survey-based study	17

Anticoagulation plus antiplatelet therapy versus anticoagulation alone following iliac vein stent implantation in acute and subacute deep vein thrombosis: A multicenter study with propensity score mat	16
Thrombin generation assay in venous thromboembolism: A scoping review	16
A Predictive Model to Identify Pulmonary Embolism in Unselected Emergency Department Patients: Model Validation and Improvement During the COVID Era	16
Mental, emotional and social dimensions of quality of life and their relationship with physical and functional status in adults with haemophilia	16
Thromboelastography as a predictor of functional outcome in acute ischemic stroke patients undergoing endovascular treatment	16
Risk of venous thromboembolism in women with endometriosis	16
Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trial	16
Atrial fibrillation and peripheral arterial disease define MPN patients with very high risk of thrombosis	16
Rotational thromboelastometry as a biomarker for mortality — The Maastricht Intensive Care COVID cohort	16
Accuracy of physical examination in detecting central venous catheter-associated thrombosis in critically ill children	16
Editorial Board	16
Evaluation of modified pediatric sepsis-induced coagulopathy score in pediatric septic shock	16
Postoperative myocardial injury and platelet reactivity in patients undergoing vascular surgery: The platelet reactivity and postoperative myocardial injury after major vascular surgery (PROMISE) stud	15
Incidence and impact of venous thromboembolism in hospitalized patients with Crohn's disease	15
ROS-driven structural and functional fibrinogen modifications are reverted by interleukin-6 inhibition in Giant Cell Arteritis	15
The influence of metastasis on clinical outcomes in patients with cancer-associated isolated distal deep vein thrombosis: A pre-specified subgroup analysis from the ONCO DVT study	15
Performance of age-adjusted and fixed threshold D-dimer to exclude DVT in those with low pre-test probability – Single centre experience	15
Critique and advice of a multicenter mechanical thrombectomy registry in intermediate-risk PE	15
Extracellular histones promote retraction and impair lysability of platelet-rich clots	15
Clinical and economic burden of immune tolerance induction in entire patients with hemophilia A: Insights from a real-world Korean setting	15
Thrombocytopenia is associated with a dysregulated host response in severe COVID-19	15
Risk factors for hospital acquired venous thromboembolism in congenital heart disease patients: A report from the children's hospital acquired thrombosis (CHAT) consortium	14
DOACs plasma levels in relation to clinical outcome. How far have we come?	14
Recurrent mechanical prosthetic valve thrombosis: Another clinical challenge	14
The course of pulmonary embolism in individuals recovered from COVID-19	14
Elevated plasma levels of factor VIII enhance arterial thrombus formation on erosive smooth muscle cell-rich neointima but not normal intima in rabbits	14
The role of platelets in the regulation of myeloid-derived suppressor cells in immune thrombocytopenia	14
Long-term recurrence, bleeding, and mortality after first-time subsegmental pulmonary embolism compared to more proximal pulmonary embolism: Findings from the TROLL registry	14
Risk of venous thromboembolism in first-degree relatives of affected patients compared with general population	14
Protein disulfide isomerase 1 (PDIA1) regulates platelet-derived extracellular vesicle release	14
The safety of direct oral anticoagulants use during lactation: A systematic review	14
Trends in ischemic heart disease and thromboembolism-related mortality in the United States, 1999–2024: A population-based analysis using CDC WONDER Data	14
Prospective comparison of viscoelastic coagulation monitor (VCM) and rotational thromboelastometry (ROTEM) in the assessment of cirrhosis coagulopathy	14
The Attend-PE model: A feasibility study of a structured follow-up care model for patients with pulmonary embolism.	14
Descriptive analysis of the Nationwide START2 antiphospholipid registry: Clinical and laboratory characteristics of patients with persistently positive antiphospholipid antibodies	14
Prolonged D-dimer elevation after COVID-19: diagnostic noise or residual risk in suspected pulmonary embolism?	14
DOAC Score for prediction of major bleeding in patients with venous thromboembolism: Findings from the RIETE registry	13
Patient characteristics, treatment patterns, and clinical outcomes in patients hospitalized with factor Xa inhibitor-associated major bleeds: A report from the REVERXaL study	13
Venous thromboembolism in women with hormone-dependent breast cancer. To continue or discontinue hormonal treatment? Insights from the RIETE registry	13
Increased contact system activity three months after starting combined oral contraceptives	13
Identification of two de novo variants causing inherited antithrombin deficiency by quantitative analysis of variant alleles	13
The contact system in chronic kidney disease and hemodialysis – A cross-sectional study	13
In Memory of Dr. Jeffrey Ginsberg	13
Platelets provide robustness of spatial blood coagulation to the variation of initial conditions	13
Editorial Board	13
Changes in right ventricular function in patients with acute pulmonary thromboembolism as assessed by transthoracic echocardiography: A one-year follow-up study	13
Air pollution impacts on in-hospital case-fatality rate of ischemic stroke patients	13
Hemostatic considerations for gender affirming care	12
Mechanisms of cerebral venous sinus thrombosis due to essential thrombocythemia: Current status and future perspectives	12
Low recurrent thrombosis rates in single positive antiphospholipid syndrome regardless of type of anticoagulation	12
Association between coagulation activity and clinical and imaging outcomes in acute ischemic stroke patients - A sub-study of the MR CLEAN NO-IV trial	12
Differential regulation of human thrombospondin-1 upon systemic desmopressin versus endotoxin challenge	12
Who are we bridging? Description of warfarin patients receiving injectable bridging therapy	12
Risks of bleeding and thromboembolic events in patients undergoing colonoscopy on uninterrupted and interrupted anticoagulant therapy in real-world setting	12
Thymidine phosphorylase mediates SARS-CoV-2 spike protein enhanced thrombosis in K18-hACE2TG mice	12
A systematic review and meta-analysis of periprocedural bridging for patients with mechanical heart valves undergoing non-cardiac interventions	12
Performance of the 4-Level Pulmonary Embolism Clinical Probability Score (4PEPS) in the diagnostic management of pulmonary embolism: An external validation study	12
Treating the mind and body: implementation of a psychosocial wellbeing assessment in the deep vein thrombosis clinic	12
Perinatal stroke and hypofibrinogenemia: Is the new missense fibrinogen variant γ p.Gly310Glu the cause of the procoagulant state?	12
Machine learning prediction of venous thromboembolism after surgeries of major sellar region tumors	12
Characteristics and outcome of a territory-wide cohort study of patients with acquired hemophilia A in Hong Kong	12
Perioperative factor XIII and viscoelastic measurements of open compared to minimal invasive major upper gastrointestinal surgery– A prospective observational study	12
Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial	12
A novel F7 mutation (p.Gly217Arg) associated with infantile intracranial hemorrhage successfully managed with rFVIIa	12
Catheter-related thrombosis in oncology: A retrospective analysis of 803 long-term central venous catheters	12
Trends of hospital admissions due to acute limb ischemia and venous thromboembolism in Austria: A population-wide observational analysis from 2009 to 2023	12
Identification of hematuria with a natural language processing model and validation of hematuria diagnosecodes	12
Outcomes of IVF treatments in women with antiphospholipid antibodies or antiphospholipid syndrome	12
CXCL13/CXCR5 axis facilitates TFH expansion and correlates with disease severity in adults with immune thrombocytopenia	11
Barriers and facilitators to healthy lifestyle behaviours for people living with post pulmonary embolism syndrome. A qualitative study exploring participants lived experiences	11
Shiga toxin down-regulates ERG protein in endothelial cells and impairs angiogenesis	11
Can edoxaban be used at extremes of bodyweight and in patients with a creatinine clearance ≥95 ml/min? – A population pharmacokinetic analysis	11
A real-world pharmacovigilance analysis of the FDA adverse event reporting system database for emicizumab	11
Neutrophil extracellular traps formation may be involved in the association of propranolol with the development of portal vein thrombosis	11
Mitochondrial DNA copy number and its association with venous thromboembolism in patients with cancer	11
Erythrocyte rheology is altered in haemophilia patients with advanced arthropathy. A case-control study	11
Interaction between LRP1 and PAI-1 in lower extremity deep venous thrombosis	11
Long-term clinical outcomes in older patients with acute venous thromboembolism who have renal impairment	11
Prognostic value of an automated thrombin generation assay in COVID-19 patients entering hospital: A multicentric, prospective observational study	11
Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Correspondence	11

Letter to the editor regarding ‘efficacy of Radiosynoviorthesis on clinical outcomes in persons with haemophilia. A systematic review and meta-analysis’	11
Added IMPACT: The first successful natural birth using certolizumab in obstetric APS	11
Platelets in pregnancy - protector or adversary?	11
Patient-parent perspectives in designing pediatric venous thromboembolism research: A qualitative study	11
Adjusted global antiphospholipid syndrome score (aGAPSS) is useful to predict relapses in patients with retinal vein occlusion	11
Incidence and risk factors of post-thrombotic syndrome in patients with isolated calf vein thrombosis. Findings from the GARFIELD-VTE registry	11
COVID-19 associated Venous Thromboembolism (VTE) burden in Black women: Findings of Veterans Affairs COVID-19 Shared Data	11
Prognosis after cerebral venous thrombosis: Mortality during initial admission and at 30 days and one year after discharge in a large Canadian population-based cohort	11
Dielectric blood coagulometry to evaluate coagulation activity in patients prescribed factor Xa inhibitors undergoing elective surgery: A prospective observational study	10
Cytochalasins modulate donor responsiveness in functional assays for heparin-induced thrombocytopenia	10
Editorial Board	10
Management strategies and clinical outcomes of venous thromboembolism in patients with antiphospholipid syndrome in the direct oral anticoagulant era: Insight from the COMMAND VTE Registry-2	10
Editorial Board	10
Prognostic role of serial electrocardiographic changes in patients with acute pulmonary embolism. Data from the Italian Pulmonary Embolism Registry	10
Aspirin dose, urinary thromboxane and prostacyclin metabolites, and clinical outcome in acute coronary syndrome: A nested case-control study from CURRENT-OASIS 7	10
Clinical and endoscopic findings in patients with acute gastrointestinal bleeding associated with direct oral anticoagulants: Results from a single-center prospective cohort study	10
Scoping review of current evidence on the incidence of Venous thromboembolism (VTE) in the East Asian population	10
Defibrotide mitigates endothelial cell injury induced by plasmas from patients with COVID-19 and related vasculopathies	10
Natural history of untreated acute pulmonary embolism in patients with cancer: A retrospective cohort of missed pulmonary emboli	10
Patients with multiple myeloma and monoclonal gammopathy of undetermined significance have variably increased thrombin generation and different sensitivity to the anticoagulant effect of activated pro	10
Characterization of a prothrombotic phenotype using thrombin generation and thrombin activity in cirrhosis and portal hypertension	10
In-hospital outcomes of Ticagrelor versus Clopidogrel in high bleeding risk patients with acute coronary syndrome: Findings from the CCC-ACS project	10
Editorial Board	10
Editorial Board	10
CIB1 and platelet integrin αIIbβ3: Molecular mechanisms, disruption strategies and antithrombotic opportunities	10
Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation - A meta-analysis	10
Tissue factor expression in monocyte subsets during human immunothrombosis, endotoxemia and sepsis	10
Venous thromboembolism prevention in ambulatory oncology: A multi-method evaluation of the Vermont Model to inform adaptation to an oncology-delivered model	10
Dynamics of troponins and 30-day mortality in hospitalized patients with pulmonary embolism	10
Disulfide bond control of platelet αIIbβ3 integrin	10
Understanding European patterns of deprescribing antithrombotic medication during end-of-life care in patients with cancer	10
Anti-Xa Levels with Venous Thromboembolism Prophylaxis in Critical Care: A Systematic Review and Meta-Analysis	10
Efficacy and safety of antithrombin or recombinant human thrombomodulin in the treatment of disseminated intravascular coagulation: A systematic review and meta-analysis	10
Management of venous thromboembolism in stroke: A deep appraisal exposing discordance in guideline quality and recommendations	10
Molecular basis of clot retraction and its role in wound healing	10
Exploration of rotational thromboelastometry (ROTEM) to characterize the coagulation profiles of newly diagnosed pediatric leukemia patients	10
Anticoagulation therapy vs clinical surveillance in isolated subsegmental pulmonary embolism: a systematic review and meta-analysis	9
Long term recovery of right ventricular function after treatment of intermediate and high risk pulmonary emboli	9
Tigecycline-associated hypofibrinogenemia: A single center, retrospective, controlled study	9
Depression and anxiety up to two years after acute pulmonary embolism: Prevalence and predictors	9
The efficacy and safety of andexanet alfa in the treatment of anticoagulation-related major bleedings: An Italian perspective	9
Modest performance of risk-prediction models for anticoagulant-related bleeding in patients with chronic liver disease	9
Influence of primary cancer site on clinical outcomes of anticoagulation for associated venous thromboembolism	9
The heat shock protein DNAJB2 as a novel biomarker for essential thrombocythemia diagnosis associated with immune infiltration	9
von Willebrand factor and fibrin monomer - induced septic shock coagulation typing: Clinical comparison between thrombotic thrombocytopenic purpura - like syndrome and sepsis - induced coagulopathy wi	9
Effectiveness and safety of anticoagulants among venous thromboembolism cancer patients with and without brain cancer	9
Evaluation of patient experiences with a structured home treatment pathway for pulmonary embolism using direct oral anticoagulants	9
Health-related quality of life associated with warfarin and direct oral anticoagulants in venous thromboembolism	9
To clot, or not to clot: The dilemma of hormone treatment options for menopause	9
Effect of regular exercise training on platelet function in patients with cardiovascular disease and healthy individuals: A systematic review	9
JAK2V617F-positive extracellular genomic materials drive endothelial inflammation and thrombosis in myeloproliferative neoplasms	9
SARS-CoV-2 infection, vaccination and acquired hemophilia: Correspondence	9
Isocitrate dehydrogenase mutation and risk of venous thromboembolism in glioma: A systematic review and meta-analysis	9
Additive effect of factor X on the structure and stability of activated factor VII-induced fibrin clot in hemophilic plasma with inhibitor	9
Thrombectomy in high-risk pulmonary embolism – device versus thrombolysis: rationale and design of the TORPEDO-NL investigator-initiated, academically-sponsored, multicenter, open-label randomized con	9
Management options for pediatric venous thromboembolic disease: Beyond anticoagulation with endovascular therapies	9
Anticoagulation with argatroban using hemoclot™ targets is safe and effective in CARDS patients receiving venovenous extracorporeal membrane oxygenation: An exploratory bi-centric cohort study	9
Early immune tolerance induction is a unique predictor of favorable outcomes in hemophilia A children with intron 22 inversion and high-responding inhibitors	9
Cold exposure promotes thrombotic risk in ischemic stroke by activating the platelet cGAS-STING pathway	9
COVID-19 venous thromboembolism prophylaxis guidelines in pediatrics	9
The differential formation and composition of leukocyte-platelet aggregates induced by various cellular stimulants	9
Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Rationale and methodology of the CORONA-VTE-Network study	9
Platelet and endothelial cell activation in antiretroviral therapy-treated African women living with HIV and obesity	9
Risk of bleeding in pulmonary embolism patients concomitant with COVID-19 undergoing extended anticoagulation: A multicenter cohort study	9
Epigenetic repression of THBD transcription by BRG1 contributes to deep vein thrombosis	9
Clinical prediction tool to identify children at risk of pulmonary embolism	8
Antiplatelet and anticoagulant therapies in hereditary hemorrhagic telangiectasia: A large French cohort study (RETROPLACOTEL)	8
Acquired factor XI deficiency in paediatrics patients: A French series and review of literature cases	8
Exploring anti-Xa activity and its correlation with C-Reactive Protein in Intensive Care Unit patients receiving a therapeutic dosage of nadroparin	8
20-HETE induced platelet activation via a GPR75-independent pathway	8
Treatment patterns and outcomes of second-line rituximab and thrombopoietin receptor agonists in adult immune thrombocytopenia: A Canadian retrospective cohort study	8
Prolonged duration of pharmacological thromboprophylaxis following oncologic surgery: A systematic review and meta-analysis of RCTs	8
Differential prognosis of patients that are candidates for standard, short or prolonged dual antiplatelet treatment discharged after an acute coronary syndrome	8
Subject: Letter to the editor regarding the article “A systematic review on the effects of direct oral anticoagulants on cancer growth and metastasis in animal models”	8
Editorial Board	8
Editorial Board	8
Efficacy and safety of prophylaxis and treatment of bleeding events with a novel fibrinogen concentrate from human plasma in patients with congenital fibrinogen deficiency	8
Combined exome and RNA-seq analysis in patients with rare non-syndromic inherited brain arteriovenous malformation suggests a novel function for PTPN13 in arterial specification	8
Prognostic significance of saddle pulmonary embolism a post hoc analysis of the PROTECT cohort study	8
Prevalence of antiphospholipid antibody syndrome misclassification in an academic health system	8
Chemotherapy alters thrombomodulin and factor VIIIc expression resulting in acquired activated protein C resistance and enhanced thrombin generation in cancer associated thrombosis	8
Apixaban thromboprophylaxis in ambulatory patients with cancer and obesity: Insights from the AVERT trial	8
Blood group non-O is not associated with long-term adverse outcomes in patients undergoing percutaneous coronary intervention	8
Panel of genetic risk markers for prediction of susceptibility towards venous thromboembolism (VTE)	8
D-dimer to fibrinogen ratio predicts early neurological deterioration in ischemic stroke with atrial fibrillation	8
Risk of thromboembolism according to statin treatment in patients with cancer: A nationwide nested case-control study	8
Oral anticoagulants and cognitive impairment in patients with atrial fibrillation: A systematic review with meta-analysis and trial sequential analysis	8
Anticoagulation stewardship in the ambulatory settings of long-term care and rehabilitation - A multi-centric descriptive pilot study	8
Hemostatic alterations in metabolic dysfunction-associated steatotic liver disease (MASLD) and their link to venous thromboembolism (VTE)	8
Late venous thromboembolism in survivors of adolescent and young adult cancer: A population-based study in California	8
Phenotype, genotype, and laboratory assessment of congenital fibrinogen disorders: Data from the Rare Bleeding disorders in the Netherlands study	8
Techniques for measuring NETosis: A critical literature review and outlook for standardization	8
Response to letter to the editor	8
Prothrombin complex concentrate for direct factor Xa inhibitor-associated bleeding or before urgent surgery	8
Prothrombotic plasma fibrin clot phenotype is associated with spontaneous echo contrast in atrial fibrillation: The role of protein carbonylation	8